Congratulations! You Just Acquired A Trial Master File. Now What?
Source: Cencora PharmaLex
In an industry filled with mergers and acquisitions (M&As), obtaining responsibility for an existing Trial Master File (TMF) is not uncommon. It can be extremely challenging to transition responsibility smoothly, however, particularly with an active TMF or one from an older study.
Following are common issues Phlexglobal’s TMF experts encounter with an acquired Trial Master File:
- No workable index
- Missing, inconsistent, and corrupted content
- Mix of paper and electronic documents
- Multiple file formats for the electronic files, such as PDFs, ZIP files, and annotation attachments
- Incomplete audit logs
- Key essential documents in local languages that have not been translated
Thoughtful planning while considering what regulatory authorities will want to see in your TMF will help to reduce issues and ensure inspection-readiness of the Trial Master File for an acquired product or study.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Cencora PharmaLex
This website uses cookies to ensure you get the best experience on our website. Learn more